YayaNews LogoYaya Financial News
SECTION

#Parabilis Medicines

Total 2 related articles

Live wire →

NewsTag

Featured

Healthcare Weekly: GSK, Parabilis Medicines, and Novo Nordisk in Focus
Lead report
美股

Lead report

Healthcare Weekly: GSK, Parabilis Medicines, and Novo Nordisk in Focus

A deep dive into three key developments in the US healthcare sector this week: GSK's RSV vaccine progress, Parabilis Medicines' rare disease breakthrough, and Novo Nordisk's GLP-1 competition and capacity expansion, offering investment insights.

YayaNews2026-06-14 21:263 min
来源: Seeking Alpha
美股

Parabilis Medicines IPO Priced at $19 Per Share, Upsized Offering

Biotech firm Parabilis Medicines completes IPO at $19 per share, upsizing to 12 million shares and raising approximately $228 million, as market focuses on its precision medicine pipeline progress.

YayaNews2026-06-10 15:033 min来源: Seeking Alpha
Parabilis Medicines IPO Priced at $19 Per Share, Upsized Offering

More Related Articles